arrow
Back
G

Guochuan Tsai

University of California System

53H-index
115Paper Count
1.2WCitation Count
Published Papers 23
Publication Date
The Development of a Regulator of Human Serine Racemase for N-Methyl-D-aspartate Function
err2024-04-12
err1
errOAAI
errLu, Lu-Ping; Chang, Wei-Hua; Mao, Yi-Wen; Cheng, Min-Chi; Zhuang, Xiao-Yi; Kuo, Chi-Sheng; Lai, Yi-An; Shih, Tsai-Miao; Chou, Teh-Ying; Tsai, Guochuan Emil
errShare
errSave
errShare
errSave
Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial
err2015-12-22
err58
errOAAI
errLin, Chun-Yuan; Liang, Sun-Yuan; Chang, Yue-Cune; Ting, Shuo-Yen; Kao, Ching-Ling; Wu, Yu-Hsin; Tsai, Guochuan E.; Lane, Hsien-Yuan
errShare
errSave
Nuclear receptor TLX stimulates hippocampal neurogenesis and enhances learning and memory in a transgenic mouse model
err2014-06-10
err61
errOAAI
errMurai, Kiyohito; Qu, Qiuhao; Sun, GuoQiang; Ye, Peng; Li, Wendong; Asuelime, Grace; Sun, Emily; Tsai, Guochuan E.; Shi, Yanhong
errShare
errSave
Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
err2014-05-01
err110
PREAI
errLin, Chieh-Hsin; Chen, Ping-Kun; Chang, Yue-Cune; Chuo, Liang-Jen; Chen, Yan-Syun; Tsai, Guochuan E.; Lane, Hsien-Yuan
errShare
errSave
Add-on Treatment of Benzoate for Schizophrenia A Randomized, Double-blind, Placebo-Controlled Trial of D-Amino Acid Oxidase Inhibitor
err2013-12-01
err197
errOAAI
errLane, Hsien-Yuan; Lin, Ching-Hua; Green, Michael F.; Hellemann, Gerhard; Huang, Chih-Chia; Chen, Po-Wei; Tun, Rene; Chang, Yue-Cung; Tsai, Guochuan E.
errShare
errSave
Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression
err2013-11-01
err120
PREAI
errHuang, Chih-Chia; Wei, I-Hua; Huang, Chieh-Liang; Chen, Kuang-Ti; Tsai, Mang-Hung; Tsai, Priscilla; Tun, Rene; Huang, Kuo-Hao; Chang, Yue-Cune; Lane, Hsien-Yuan; Tsai, Guochuan Emil
errShare
errSave
Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia
err2013-05-01
err170
PREAI
errLin, Chieh-Hsin; Huang, Chieh-Liang; Chang, Yue-Cune; Chen, Po-Wei; Lin, Chun-Yuan; Tsai, Guochuan E.; Lane, Hsien-Yuan
errShare
errSave
Glutamate signaling in the pathophysiology and therapy of schizophrenia
err2012-02-01
err128
PREAI
errLin, Chieh-Hsin; Lane, Hsien-Yuan; Tsai, Guochuan E.
errShare
errSave
Reliability and validity of three Chinese-version tasks of Mayer-Salovey-Caruso Emotional Intelligence Test
err2010-08-15
err25
PREAI
errMa, Wei-Fen; Tsai, Guochuan E.; Chang, Jane Pei-Chen; Lane, Hsien-Yuan
errShare
errSave
Sarcosine (N-Methylglycine) treatment for acute schizophrenia: A randomized, double-blind study
err2008-01-01
err146
PREAI
errLane, Hsien-Yuan; Liu, Yi-Ching; Huang, Chieh-Liang; Chang, Yue-Cune; Liau, Chun-Hui; Perng, Cheng-Hwang; Tsai, Guochuan E.
errShare
errSave
Low cerebrospinal fluid glutamate and glycine in refractory affective disorder
err2007-01-01
err125
PREAI
errFrye, Mark A.; Tsai, Guochuan E.; Huggins, Teresa; Coyle, Joseph T.; Post, Robert M.
errShare
errSave
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to clozapine for the treatment of schizophrenia
err2006-09-01
err154
PREAI
errLane, Hsien-Yuan; Huang, Chieh-Liang; Wu, Po-Lun; Liu, Yi-Ching; Chang, Yue-Cune; Lin, Pao-Yen; Chen, Po-Wei; Tsai, Guochuan
errShare
errSave
Gene knockout of glycine transporter 1: Characterization of the behavioral phenotype
err2004-05-24
err200
errOAAI
errTsai, G; Ralph-Williams, RJ; Martina, M; Bergeron, R; Berger-Sweeney, J; Dunham, KS; Jiang, ZC; Caine, SB; Coyle, JT
errShare
errSave
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine
err2002-03-01
err99
PREAI
errGoff, DC; Hennen, J; Lyoo, IK; Tsai, G; Wald, LL; Evins, AE; Yurgelun-Todd, DA; Renshaw, PF
errShare
errSave
A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia
err1999-01-01
err352
PREAI
errGoff, DC; Tsai, G; Levitt, J; Amico, E; Manoach, D; Schoenfeld, DA; Hayden, DL; McCarley, R; Coyle, JT
errShare
errSave